on Antimicrobial resistance
Antimicrobial resistance (AMR) develops when bacteria, fungi or viruses are exposed to antibiotics, antifungals or antivirals.
As a result, the antimicrobials become ineffective and infections may persist. In addition, medical interventions including surgery, chemotherapy and stem cell therapy may become impossible.
AMR is considered the biggest global threat of Health and Food Safety.
AMR Insights is committed to eliminating Antimicrobial resistance because it does not accept that millions of innocent people need to die as a result of resistant bacteria and other microorganisms.
NEW INITIATIVE TAKES ON THE ANTIBIOTIC INNOVATION CHALLENGE
The world is losing its most powerful tool in healthcare: antibiotics. The reason is rapidly rising antibiotic-resistant infections – also called antimicrobial resistance, or AMR.
09/07/2020 - 09/07/2020 | Online from Berlin
Webinar: Challenging the Anti Microbial Resistance Crises
Antimicrobial resistance is a global threat that cannot be ignored: what is being done to innovate new solutions?
23/07/2020 - 23/06/2020 | Online webinar
ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
The meeting is focussed on the challenges of developing new agents for AMR that stretches from medicinal chemistry right through to the collective efforts of the international community to produce new antibiotics.
01/09/2020 - 04/09/2020 | Dublin (Ireland)
Latest news on AMR
The UK and Indonesia announces MoU on Health Cooperation and a Grant Agreement on Antimicrobial Resistance Surveillance
The UK and Indonesia have signed a Memorandum of Understanding on health cooperation and its Joint Action Plan. The two countries have also signed a Grant Agreement for the Fleming Fund partnership on antimicrobial resistance (AMR) surveillance in Indonesia.